Submitted on May 2, 2019 - USP Comment Letter to FDA on on draft guidance, “Nonproprietary Naming of Biological Products: Update.” Docket No. FDA-2013-D-1543.
USP-comments-to-FDA-on-CBER-nomenclature-1.pdf
(170.15 KB)
Submitted on May 2, 2019 - USP Comment Letter to FDA on on draft guidance, “Nonproprietary Naming of Biological Products: Update.” Docket No. FDA-2013-D-1543.